Alkami Technology, Inc.
NASDAQ:ALKTSoftware - Application
-$0.40 today
- Market cap
- $1.44B
- Beta
- 0.57
- P/E (TTM)
- -31.4
- EPS (TTM)
- -$0.47
Volume 2.00M
Average 1.56M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Alkami Technology, Inc.
NASDAQ:ALKT
Intrinsic Alpha fair value
Locked
Current Price
$13.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +29.5% | +16.1% (3yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at +29.5% over three years. Forward estimates point to Revenue at +16.1% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
ACI Worldwide, Inc. NASDAQ:ACIW | $6.09B | $60.79 | Overvalued | 21.9 | +27.39% |
NCR Atleos Corporation NYSE:NATL | $3.57B | $48.23 | Undervalued | 18.2 | +39.99% |
nCino, Inc. NASDAQ:NCNO | $2.41B | $22.76 | Overvalued | 124.5 | -10.35% |
Diebold Nixdorf, Incorporated NYSE:DBD | $1.85B | $55.05 | Undervalued | 26.9 | -14.37% |
Blend Labs, Inc. NYSE:BLND | $251.46M | $1.07 | Not rated | -71.2 | -69.58% |
Continue the stock analysis
Jump to another research area for this company.